-+ 0.00%
-+ 0.00%
-+ 0.00%

FIBROBIOLOGICS ADVANCES PATIENT DOSING FOR PHASE 1/2 CLINICAL TRIAL OF CYWC628 FOR THE TREATMENT OF DIABETIC FOOT ULCERS

Reuters·06/16/2026 12:30:01

Please log in to view news